Yu Xiaoling, Han Lifen, Lin Yunping, et al. Security of fructose infusion in patients with chronic hepatitis B complicated with type 2 diabetes[J]. Journal of Chongqing Medical University, 2017,42(7):813-816.
Yu Xiaoling, Han Lifen, Lin Yunping, et al. Security of fructose infusion in patients with chronic hepatitis B complicated with type 2 diabetes[J]. Journal of Chongqing Medical University, 2017,42(7):813-816. DOI: 10.13406/j.cnki.cyxb.001345.
Objective:To investigate the effects of fructose infusion on patients with chronic hepatitis B complicated with type 2 diabetes. Methods:Seventy-one cases were randomized into the control group(n=38)and experiment group(n=33). The patients in control group used 5% glucose injection 250 m L added 3 U insulin as solvent infusion of oglycyrrhizinate magnesium injection or diammonium glycyrrhizinate injection and those in test group used 10% fructose injection 250 m L
lasting for 3 days. The serum creatinine
blood urea nitrogen and serum uric acid levels were monitored in the first day and the fifth day on patients. Results:The serum creatinine
blood urea nitrogen and serum uric acid levels had no significant difference between two groups(P>0.05). Conclusion:Fructose injection had no effect on serum creatinine
urea nitrogen and serum uric acid in patients with chronic hepatitis B complicated with type 2 diabetes. Fructose as licorice acid formulation vehicle infusion for patients of chronic hepatitis B with type 2 diabetes is safe and reliable.